Examination Report |
1 | Power of Attorney | 01 Jan 2014 |
1 | TM-1 | 01 Jan 2014 |
2 | Power of Attorney | 01 Jan 2014 |
2 | TM-1 | 01 Jan 2014 |
3 | Reply to Exam Report (MIS-R) | 14 Jul 2015 |
4 | Authorization Letter | 07 Nov 2016 |
5 | Order | 15 Nov 2016 |
6 | Journal Copy | 21 Nov 2016 |
7 | Certificate | 13 Apr 2017 |
8 | TM-R(RENEWAL OF TRADE MARK) | 01 Jan 2024 |
1 | Hearing Notice (Show Cause) | 2974427 | 1524223 | 03 Feb 2016 |
2 | Hearing Notice (Adjourned) | 4121026 | 1947889 | 18 Oct 2016 |
3 | Tribunal ABA Notice for : 2652941 | 4213725 | 1962553 | 15 Nov 2016 |
4 | O3 NOTICE | 16149237 | 6248384 | 29 Sep 2023 |
5 | RENEWAL INTIMATION LETTER | 17038477 | 05 Jan 2024 |
The application for Intaprol was made on 01 January 2014.
The trademark applicant for Intaprol is INTAS PHARMACEUTICALS.
Intaprol is applied in class(es) 5.
Application for Intaprol is on Registered stage.
Application Id allotted to Intaprol is 2652941.
Trademark agent or attorney for the application is Y. J. Trivedi & Co.
Intaprol filed with the Intellectual property office as a WORD.